Surveillance of cystic fibrosis patients with multi-drug resistant Gram-negative rods

International Journal of Hygiene and Environmental Health

Volumn 209, Issue 4, 2006, Pages 333-336

  Vonberg, Ralf Peter ^a   Wolter, Anneke ^a   Ziesing, Stefan ^a   Gastmeier, Petra ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cystic fibrosis; Epidemiology; Multi drug resistance; Surveillance

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BACTERIUM DETECTION; CYSTIC FIBROSIS; DRUG SENSITIVITY; FEMALE; GERMANY; GRAM NEGATIVE BACTERIUM; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NEWBORN; PSEUDOMONAS AERUGINOSA; UNIVERSITY HOSPITAL;

NEGIBACTERIA;

EID: 33745269845     PISSN: 14384639     EISSN: 1618131X     Source Type: Journal    
DOI: 10.1016/j.ijheh.2006.03.001     Document Type: Article

References (19)

1. Al Aloul M., Crawley J., Winstanley C., Hart C.A., Ledson M.J., and Walshaw M.J. Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax 59 (2004) 334-336
2. Bitter-Suermann D., Marre R., Ullmann U., and Wiedemann B. GENARS (German Network on Antimicrobial Resistance Surveillance). Chemother. J. 7 (1998) 155-156
3. Canton R., Valdezate S., Vindel A., Sanchez D.S., Maiz L., and Baquero F. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates. Pediatr. Pulmonol. 35 (2003) 99-107
4. Chaparro C., Maurer J., Gutierrez C., Krajden M., Chan C., Winton T., Keshavjee S., Scavuzzo M., Tullis E., Hutcheon M., and Kesten S. Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am. J. Respir. Crit. Care Med. 163 (2001) 43-48
5. Chen J.S., Witzmann K.A., Spilker T., Fink R.J., and LiPuma J.J. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J. Pediatr. 139 (2001) 643-649
6. Cheng K., Smyth R.L., Govan J.R., Doherty C., Winstanley C., Denning N., Heaf D.P., van Saene H., and Hart C.A. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 348 (1996) 639-642
7. Chernish R.N., and Aaron S.D. Approach to resistant Gram-negative bacterial pulmonary infections in patients with cystic fibrosis. Curr. Opin. Pulm. Med. 9 (2003) 509-515
8. Conway S.P., Brownlee K.G., Denton M., and Peckham D.G. Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis. Am. J. Respir. Med. 2 (2003) 321-332
9. Fogarty A., Hubbard R., and Britton J. International comparison of median age at death from cystic fibrosis. Chest 117 (2000) 1656-1660
10. Goss C.H., Otto K., Aitken M.L., and Rubenfeld G.D. Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 166 (2002) 356-361
11. Jones A.M., Govan J.R., Doherty C.J., Dodd M.E., Isalska B.J., Stanbridge T.N., and Webb A.K. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 358 (2001) 557-558
12. Jones A.M., Govan J.R., Doherty C.J., Dodd M.E., Isalska B.J., Stanbridge T.N., and Webb A.K. Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak. Thorax 58 (2003) 525-527
13. Jorgensen I.M., Johansen H.K., Frederiksen B., Pressler T., Hansen A., Vandamme P., Hoiby N., and Koch C. Epidemic spread of Pandoraea apista, a new pathogen causing severe lung disease in cystic fibrosis patients. Pediatr. Pulmonol. 36 (2003) 439-446
14. Paull A., and Morgan J.R. Emergence of ceftriaxone-resistant strains of Pseudomonas aeruginosa in cystic fibrosis patients. J. Antimicrob. Chemother. 18 (1986) 635-639
15. Pedersen S.S., Koch C., Hoiby N., and Rosendal K. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. J. Antimicrob. Chemother. 17 (1986) 505-516
16. Saiman L., and Siegel J. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect. Control Hosp. Epidemiol. 24 (2003) S6-S52
17. Spencer R.C. The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia. J. Hosp. Infect. 30 Suppl (1995) 453-464
18. Vonberg R., and Gastmeier P. Isolation of infectious cystic fibrosis patients-results of a systematic review. Infect. Control Hosp. Epidemiol. 26 (2005) 401-409
19. Wust J., Frei R., Gunthard H., and Altwegg M. Analysis of restriction fragment length polymorphism and ribotyping of multiresistant Stenotrophomonas maltophilia isolated from persisting lung infection in a cystic fibrosis patient. Scand. J. Infect. Dis. 27 (1995) 499-502